Pilot Study of Maintenance Therapy With Intravenous AMANTADINE

• Status: Unknown status
• Trial end date: 2012-06-01
• Target enrollment: 0
• Participant gender: All

Summary

This is a pilot study for Maintenance Intravenous Treatment with AMANTADINE in patient with PARKINSON'S Disease who are not well balanced with medical treatment.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Rabin Medical Center
• Treatments: Amantadine

Criteria

Inclusion Criteria:

• Patients with idiopathic Parkinson disease

• Age<80

• Patients with no motor improvement under optimal treatment with anti parkinson medications

• Patients with moderate to severe dyskinesias

• Patients with PD with side effects who can not tolerate anti parkinson medications

Exclusion Criteria:

• Age>80

• Patients with Parkinson syndromes, vascular parkinsonism or drug-induced parkinsonism

• Patients with PD who developed adverse reactions to oral amantadine

• Contraindication of amantadine treatment